Epitomee MedicalEPTMF 29 EV-to-FCF is -6.22 as of Jun. 26, 2026. GuruFocus rates EPTMF with a GF Score™ of 29/100. The stock has 3 warning signs investors should review. Among 421 Medical Devices & Instruments companies, Epitomee Medical ranks worse than 237529.45% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Epitomee Medical's Enterprise Value is $59.04 Mil.
Epitomee Medical's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was $-9.49 Mil. Therefore, Epitomee Medical's EV-to-FCF for today is -6.22.
The historical rank and industry rank for Epitomee Medical's EV-to-FCF or its related term are showing as below:
EPTMF'
s EV-to-FCF Range Over the Past 10 Years
Min: -9.09 Med: -4.53 Max: 0.27
Current: -6.38
During the past 8 years, the highest EV-to-FCF of Epitomee Medical was 0.27. The lowest was -9.09. And the median was -4.53.
EPTMF's EV-to-FCF is ranked worse than 100% of 421
companies
in the Medical Devices & Instruments industry
Industry Median: 22.82
vs EPTMF: -6.38
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Epitomee Medical (OTCPK:EPTMF) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Epitomee Medical's PE Ratio (TTM) for today is calculated as:
Epitomee Medical's share price for today is $0.9892.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Epitomee Medical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was $-0.120.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Epitomee Medical EV-to-FCF Related Terms
Epitomee Medical EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Epitomee Medical's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Epitomee Medical's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Epitomee Medical EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Epitomee Medical's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Epitomee Medical's EV-to-FCF falls into.
Epitomee Medical's current Enterprise Value is $59.04 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Epitomee Medical's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was $-9.49 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Epitomee Medical (EPTMF) has a EV-to-FCF of -6.22 as of Jun. 26, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Epitomee Medical and its competitors. According to the industry distribution chart, Epitomee Medical ranks #999999 out of 421 companies in the Medical Devices & Instruments industry.
Is Epitomee Medical's EV-to-FCF too high?
Epitomee Medical's current EV-to-FCF is -6.22. Based on the distribution chart, Epitomee Medical ranks #999999 out of 421 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Epitomee Medical has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does Epitomee Medical's EV-to-FCF compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Epitomee Medical ranks #999999 out of 421 companies for EV-to-FCF. This places Epitomee Medical in the lower half of its industry. The industry median EV-to-FCF is 22.82. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 22.82, based on 421 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Epitomee Medical and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 22.82 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Epitomee Medical's current EV-to-FCF is -6.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Epitomee Medical stock overvalued right now?
Epitomee Medical (EPTMF) has a current EV-to-FCF of -6.22. The current EV-to-FCF is -6.22. Epitomee Medical's overall GF Score™ is 29/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Epitomee Medical (EPTMF), the current EV-to-FCF is -6.22 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
EPTMF has been successfully added to your 
